Researchers Identify Lupus Trigger
Researchers identified three proteins, called Toll-Like Receptors (TLRs), that can cause the immune system to turn against the body.
CombinatoRx to Merge with Neuromed
CombinatoRx has signed an all-stock merger agreement with Neuromed.
Cynosure, Unilever Join Forces to Develop Home-Use Aesthetic Devices
The multi-year agreement will focus on the skin rejuvenation segment of the marketplace.
AST to Resume Clinical Trials of Spinal Stabilization Device
Applied Spine Technologies has received permission from the FDA to restart a clinical trial of Stabilimax NZ.
BioGlue Used In Over Half a Million Surgeries
CryoLife’s BioGlue Surgical Adhesive has been used in more than 500,000 surgical procedures worldwide since its introduction in 1998.
Aureon Featured In TV Segment
Aureon Laboratories, a developer of predictive tests for cancer care, has been featured in a cable television segment produced by the Yonkers Chamber of Commerce.
Clarient Files Registration Agreement With SEC
Clarient has filed a registration statement with the Securities and Exchange Commission on Form S-3 relating to shares of Clarient owned by Safeguard.
SyntheMed Nominated for Frost & Sullivan Award
The Iselin, NJ-based company was recognized for its REPEL-CV Anti-Adhesion Barrier.
CNS Closes $1M Bridge Loan, Completes Clinical Trial Enrollment
The money will allow CNS Response, based in Costa Mesa, Calif., to complete an upcoming depression study.
FDA Approves Kowa’s Cambia for Migraines
In clinical trials, Cambia provided statistically significant onset of relief of migraine pain within 15 to 30 minutes.